The European Brain Council (EBC) is pleased to be featured in Health Europa, health publication committed to highlighting the latest trends and developments in health and healthcare from across Europe and beyond, and the inaugural issue of Aging Brain, an Open Access journal that complements Neurobiology of Aging which, in its 40th anniversary in 2020, is the premier journal in the field of aging neuroscience.
Health Europa: “The importance of prioritising brain health”
Stephanie Kramer, EBC Head of Communications, Advocacy & Policy, discussed with Health Europa, addressing the need for collaboration, research and increased support for brain health, in the article entitles “The importance of prioritising brain health”. She explained the role and the main objectives of the EBC in the European brain health sector and the key challenges currently facing the management and treatment of brain conditions, both mental and neurological alike. It was also discussed how increased collaborative efforts between the medical, industry and policy fields could accelerate research and innovation as well as notable developments or current issues in the world of brain research, such as the growing evidence of the severe mental and neurological consequences of COVID-19.
Aging Brain: “Future of the aging brain: Bridging the gap between research and policy”
Prof. Monica Di Luca, EBC President, Frédéric Destrebecq, EBC Executive Director and Stephanie Kramer, EBC Head of Communications, Advocacy & Policy, contributed to the inaugural issue of Aging Brain with a publication on “Future of the aging brain: Bridging the gap between research and policy”, examining the current state of brain research and looking ahead at our vision for research and policy on the ageing brain in the next decades. While Brain Research, has been considered a priority for European funding, and it has been a recipient of the European budget for medical research, the significant burden of brain conditions, neurological and mental alike, on society explains the growing societal need to expand brain research in Europe and to increase the overall funding. Only through continued and coordinated support can it be hoped that real solutions will be found. Relentless prioritization efforts are therefore needed to make sure that brain disorders remain high on the health policy agenda at EU and global level.